RU96123879A - MEANS FOR TREATMENT OF FUNGAL DISEASES (OPTIONS) - Google Patents

MEANS FOR TREATMENT OF FUNGAL DISEASES (OPTIONS)

Info

Publication number
RU96123879A
RU96123879A RU96123879/14A RU96123879A RU96123879A RU 96123879 A RU96123879 A RU 96123879A RU 96123879/14 A RU96123879/14 A RU 96123879/14A RU 96123879 A RU96123879 A RU 96123879A RU 96123879 A RU96123879 A RU 96123879A
Authority
RU
Russia
Prior art keywords
butyloxytoluene
citric acid
treatment
nystatin
fungal diseases
Prior art date
Application number
RU96123879/14A
Other languages
Russian (ru)
Other versions
RU2139707C1 (en
Inventor
Н.С. Николаенко
М.И. Эльнатанова
Л.Н. Суркова
В.Н. Шмелева
А.К. Чуева
З.А. Золотарева
Original Assignee
ОАО Нижегородский химико-фармацевтический завод
Filing date
Publication date
Application filed by ОАО Нижегородский химико-фармацевтический завод filed Critical ОАО Нижегородский химико-фармацевтический завод
Priority to RU96123879A priority Critical patent/RU2139707C1/en
Priority claimed from RU96123879A external-priority patent/RU2139707C1/en
Publication of RU96123879A publication Critical patent/RU96123879A/en
Application granted granted Critical
Publication of RU2139707C1 publication Critical patent/RU2139707C1/en

Links

Claims (1)

1. Средство для лечения грибковых заболеваний, содержащее противогрибковый антибиотик нистатин с активностью 250000 ЕД и вспомогательные вещества, отличающееся тем, что в качестве вспомогательных веществ оно содержит антиоксиданты - бутилоксианизол и бутилокситолуол, а также кислоту лимонную пищевую, масло вазелиновое и основу - твердый жир типа А или витепсоловую смесь при следующем соотношении компонентов, г:
Нистатин - 212500 - 287500 ЕД
Бутилоксианизол - 0,000074 - 0,000076
Бутилокситолуол - 0,00014 - 0,00016
Кислота лимонная пищевая - 0,000074 - 0,000076
Масло вазелиновое - 0,047 - 0,064
Основа - Остальное
2. Средство для лечения грибковых заболеваний, содержащее противогрибковый антибиотик - нистатин с активностью 500000 ЕД и вспомогательные вещества, отличающиеся тем, что в качестве вспомогательных веществ оно содержит антиоксиданты - бутилоксианизол и бутилокситолуол, а также кислоту лимонную пищевую, масло вазелиновое и основу - твердый жир типа А или витепсоловую смесь при следующем соотношении компонентов, г:
Нистатин - 425000 - 575000 ЕД
Бутилоксианизол - 0,000074 - 0,000076
Бутилокситолуол - 0,00014 - 0,00016
Кислота лимонная пищевая - 0,000074 - 0,00076
Масло вазелиновое - 0,094 - 0,128
Основа - Остальное
3. Средство по пп. 1 и 2, отличающееся тем, что оно выполнено в виде ректального суппозитория массой (1,95 - 2,30) г.
1. An agent for the treatment of fungal diseases, containing an antifungal antibiotic nystatin with an activity of 250,000 IU and excipients, characterized in that it contains antioxidants as butyloxyanisole and butyloxytoluene, as well as citric acid, liquid paraffin and a solid fat type base A or vitepsol mixture in the following ratio of components, g:
Nystatin - 212500 - 287500 UNITS
Butyloxyanisole - 0.000074 - 0.000076
Butyloxytoluene - 0.00014 - 0.00016
Food citric acid - 0.000074 - 0.000076
Vaseline oil - 0.047 - 0.064
Basis - Else
2. An agent for the treatment of fungal diseases, containing an antifungal antibiotic nystatin with an activity of 500,000 units and excipients, characterized in that it contains antioxidants, butyloxy anisole and butyloxytoluene, as well as citric acid, liquid paraffin, and solid fat base type A or vitepsol mixture in the following ratio of components, g:
Nystatin - 425,000 - 575,000 units
Butyloxyanisole - 0.000074 - 0.000076
Butyloxytoluene - 0.00014 - 0.00016
Food citric acid - 0.000074 - 0.00076
Vaseline oil - 0,094 - 0,128
Basis - Else
3. The tool according to paragraphs. 1 and 2, characterized in that it is made in the form of a rectal suppository weighing (1.95 - 2.30) g.
4. Средство по пп. 1 и 2, отличающееся тем, что оно выполнено в виде вагинального суппозитория массой (2,35 - 2,70) г. 4. The tool according to paragraphs. 1 and 2, characterized in that it is made in the form of a vaginal suppository weighing (2.35 - 2.70) g.
RU96123879A 1996-12-24 1996-12-24 Suppository exhibiting antifungal effect (variants) RU2139707C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96123879A RU2139707C1 (en) 1996-12-24 1996-12-24 Suppository exhibiting antifungal effect (variants)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96123879A RU2139707C1 (en) 1996-12-24 1996-12-24 Suppository exhibiting antifungal effect (variants)

Publications (2)

Publication Number Publication Date
RU96123879A true RU96123879A (en) 1999-02-10
RU2139707C1 RU2139707C1 (en) 1999-10-20

Family

ID=20188289

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96123879A RU2139707C1 (en) 1996-12-24 1996-12-24 Suppository exhibiting antifungal effect (variants)

Country Status (1)

Country Link
RU (1) RU2139707C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69838338T2 (en) 1997-10-22 2008-05-21 Jens Rochester Ponikau USE OF ANTIMYKOTICA FOR THE TOPIC TREATMENT OF MUSHROOM INDUCED TISSUE SKIN INJECTION

Similar Documents

Publication Publication Date Title
PT74703A (en) Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine
SE8702907D0 (en) STABLE PHARMACEUTICAL PREPARATION CONTAINING GRANULOCYTE COLONY STIMULATING FACTOR AND PROCESS FOR PRODUCING THE SAME
HUT61031A (en) Process for producing chemically modified, stable haemoglobin substituting for non-immunogehic red blood cell, and pharmaceutical compositions comprising same as active ingredient
BE901737A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE MYOCARDIAL ISCHEMIA.
ES8503344A1 (en) Propynylaminoisoxazole derivatives.
SE8803221D0 (en) WATER SOLUBLE MONOESTERS AS SOLUBILIZERS FOR PHARMACOLOGICALLY ACTIVE COMPOUNDS AND PHARMACEUTICAL EXCIPIENTS
DE19475001I2 (en) Anthelmintic combinations of active ingredients.
CA2063273A1 (en) Surfactant compositions and methods
IT1230115B (en) PROCEDURE FOR COMBATING FUNGAL DISEASES OF PLANTS
RU96123879A (en) MEANS FOR TREATMENT OF FUNGAL DISEASES (OPTIONS)
BR8802557A (en) PHYSIOLOGICALLY ACTIVE AGENT FOR AGRICULTURAL USE
EP0274104A3 (en) 13-cis-retinoic acid for the use in compositions against the aging of the skin
ATE14982T1 (en) COMPOSITIONS CONTAINING PAROMOMYCIN FOR THE TOPICAL TREATMENT OF SKIN LEISHMANIASIS.
GT198804306A (en) CONVERSION OF PIRETROID ISOMERS IN MORE ACTIVE SPECIES.
DE59002738D1 (en) Combination preparations containing chloramphenicol, gentamicin and nystatin as active ingredients for the topical treatment of inflammatory skin diseases.
HU900210D0 (en) Herbicid composition comprising n-phenyl-tetrahydroindazol-derivatives as active ingredient acid process for preparation thereof
ATE92766T1 (en) TOPICAL WOUND REMEDIES CONTAINING INTERLEUKIN-1 PROTEINS.
DE3480706D1 (en) 5-FLUORURACILABRED COMBINATIONS AND MEDICAL COMPOSITIONS CONTAINING THEM.
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
ZA824731B (en) S-azolyl-methyl-di(tri)-thiophosphoric acid esters, processes for their preparation, and their use as pest-combating agents
IE43994L (en) Diphenylmethanes.
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation
IT1216820B (en) PROCEDURE FOR COMBATING FUNGAL DISEASES OF PLANTS
JPS568324A (en) Infectious disease remedy for external and ophthalmologic application
EG18336A (en) Insectidal composition comprising more than one active ingredients